Stoke Therapeutics Inc buy BTIG Research
Start price
05.11.25
/
50%
€19.00
Target price
05.11.26
€33.93
Performance (%)
29.47%
Price
26.01.26
€24.60
Summary
This prediction is currently active. The BUY prediction by BTIG_Research currently has a performance of 29.47%. This prediction currently runs until 05.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 0.000% | 0.000% |
| iShares Core DAX® | 1.130% | 2.184% |
| iShares Nasdaq 100 | 1.128% | -0.611% |
| iShares Nikkei 225® | 2.610% | 4.958% |
| iShares S&P 500 | -0.006% | -0.952% |
Comments by BTIG_Research for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (NASDAQ:STOK) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $39.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by BTIG_Research for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
14.10.25
14.10.25
€33.70
14.10.26
14.10.26
-7.52%
26.01.26
26.01.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€15.60
18.08.25
18.08.25
€23.93
18.08.26
18.08.26
57.69%
26.01.26
26.01.26